dc.contributor.author |
Davis, Peter |
en |
dc.date.accessioned |
2013-10-03T03:55:34Z |
en |
dc.date.issued |
1996 |
en |
dc.identifier.citation |
Health Care Analysis 4:220-222 1996 |
en |
dc.identifier.issn |
1065-3058 |
en |
dc.identifier.uri |
http://hdl.handle.net/2292/20870 |
en |
dc.relation.ispartofseries |
Health Care Analysis |
en |
dc.rights |
Items in ResearchSpace are protected by copyright, with all rights reserved, unless otherwise indicated. Previously published items are made available in accordance with the copyright policy of the publisher. Details obtained from http://www.springer.com/open+access/authors+rights?SGWID=0-176704-12-683201-0 http://www.sherpa.ac.uk/romeo/issn/1065-3058/ |
en |
dc.rights.uri |
https://researchspace.auckland.ac.nz/docs/uoa-docs/rights.htm |
en |
dc.title |
'Compassionate supply' or rejigging the choice set for pharmaceutical funding decisions? |
en |
dc.type |
Journal Article |
en |
dc.identifier.doi |
10.1007/BF02252883 |
en |
pubs.issue |
3 |
en |
pubs.begin-page |
220 |
en |
pubs.volume |
4 |
en |
pubs.end-page |
222 |
en |
dc.rights.accessrights |
http://purl.org/eprint/accessRights/RestrictedAccess |
en |
pubs.subtype |
Article |
en |
pubs.elements-id |
8897 |
en |
pubs.record-created-at-source-date |
2010-09-01 |
en |